UBS Upgrades CryoPort (CYRX) to Buy, 'Credible Growth Opportunity to Follow Well Understood Headwinds'

March 24, 2025 6:29 AM EDT Send to a Friend
(Updated - March 24, 2025 9:01 AM EDT)

UBS analyst John Sourbeer upgraded CryoPort (NASDAQ: CYRX) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login